Add Yahoo as a preferred source to see more of our stories on Google. MUMBAI (Reuters) - Biotechnology firm Biocon Ltd(BION.NS) could file a prospectus for a share listing for its research services ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Syngene International Ltd. ( (IN:SYNGENE) ) has provided an announcement.

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), reports that that its newly upgraded biologics facility (Unit 3) in Bangalore, India, will be ...

Syngene has embarked on evaluating bioequivalence of an injectable for type-2 diabetes and weight management. This was after a global pharma company was scouting for a partner to outsource its human ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved ...

Syngene had successfully demonstrated the small-scale synthesis of a novel vascular calcification inhibitor API from lab-scale to tox-batch manufacturing. This was following the request of a pharma ...

insights from industryDr Martin BiggsSales Manager, UK and IrelandSyngene, a division of the Synoptics GroupIn this interview, News Medical speaks with Dr Martin Biggs from Synoptics about Syngene's G ...

Syngene International will partner with Zumutor Biologics to screen target antigens against Zumutor’s human antibody libraries, with the goal of discovering and characterizing novel antibody clones.

BENGALURU (Reuters) -India's Syngene International Ltd aims to supply half-a-million vials of COVID-19 drug remdesivir through its local distribution partners next month, its top executive said, as ...